Drug Information

Drug General Information
Drug ID
D09RJT
Former ID
DNC009454
Drug Name
Grandisine C
Drug Type
Small molecular drug
Indication Discovery agent Investigative [528442]
Structure
Download
2D MOL

3D MOL
Formula
C16H23NO3
Canonical SMILES
CC1CC(CC2=C1C(=O)C3C4CCCN4CCC3O2)O
InChI
1S/C16H23NO3/c1-9-7-10(18)8-13-14(9)16(19)15-11-3-2-5-17(11)6-4-12(15)20-13/h9-12,15,18H,2-8H2,1H3/t9-,10-,11-,12+,15-/m0/s1
InChIKey
WNDBXOYUMYCREE-NAYUARGSSA-N
PubChem Compound ID
16086540
Target and Pathway
Target(s) Delta-type opioid receptor Target Info Inhibitor [528442]
KEGG Pathway cGMP-PKG signaling pathway
Sphingolipid signaling pathway
Neuroactive ligand-receptor interaction
PANTHER Pathway Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway
Heterotrimeric G-protein signaling pathway-Gq alpha and Go alpha mediated pathway
Enkephalin release
Opioid proenkephalin pathway
Opioid proopiomelanocortin pathway
Reactome Peptide ligand-binding receptors
G alpha (i) signalling events
WikiPathways GPCRs, Class A Rhodopsin-like
Peptide GPCRs
GPCR ligand binding
GPCR downstream signaling
References
Ref 528442J Nat Prod. 2006 Sep;69(9):1295-9.Grandisines C-G, indolizidine alkaloids from the Australian rainforest tree Elaeocarpus grandis.
Ref 528442J Nat Prod. 2006 Sep;69(9):1295-9.Grandisines C-G, indolizidine alkaloids from the Australian rainforest tree Elaeocarpus grandis.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.